Skip to content

New EACS treatment guidelines strike balance between individual choice and public health, say writers

New EACS treatment guidelines strike balance between individual choice and public health, say writers

Thank you Unusual Risks!

Thank you Unusual Risks!

Unravelling the mystery of the vaccine trials

HIV monitoring every six months is adequate for people on ART with stable viral suppression

Kamla Sanasi, from the University of South Carolina, speaking at the ID Week Conference.

The monkeys’ tale – how a vaccine might nip HIV in the bud

Louis Picker speaking at the AIDS Vaccine 2013 Conference.

Multi-disease prevention campaigns (part 1): integrating HIV into wider public health campaigns

Studies look at community vs hospital-based HIV care and medication issues

Elizabeth Neuner from the Cleveland Clinic and HIV Medicine Association chair Michael Horberg, at the ID Week Conference.

Many HIV-positive people not receiving recommended prevention counselling as part of their routine care

Who will PrEP be for?